Allianz Asset Management GmbH - ONCOGENEX PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$869,000
-46.1%
722,8360.0%0.00%
-50.0%
Q3 2015$1,612,000
-0.1%
722,836
+4.3%
0.00%0.0%
Q2 2015$1,614,000
-28.2%
692,836
-33.7%
0.00%
-33.3%
Q1 2015$2,248,000
-6.1%
1,045,6720.0%0.00%0.0%
Q4 2014$2,394,000
+71.5%
1,045,672
+100.0%
0.00%
+50.0%
Q3 2014$1,396,000
-28.4%
522,8360.0%0.00%0.0%
Q2 2014$1,950,000
-36.2%
522,836
+101.2%
0.00%
-50.0%
Q1 2014$3,055,000
+41.0%
259,8000.0%0.00%
+33.3%
Q4 2013$2,167,000
-10.0%
259,8000.0%0.00%0.0%
Q3 2013$2,408,000
-5.4%
259,8000.0%0.00%
-25.0%
Q2 2013$2,546,000259,8000.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders